Olivier Collange, Marc Lopez, Anne Lejay, Patrick Pessaux, Alexandre Ouattara, Antoine Dewitte, Thomas Rimmele, Thibaut Girardot, Darko Arnaudovski, Pascal Augustin, Nabil Chakfe, Charles Tacquard, Walid Oulehri, Laurent Zieleskiewicz, François Severac, Marc Leone, Paul Michel Mertes
BACKGROUND: Early diagnosis and prompt management of acute mesenteric ischaemia (AMI) are key to survival but remain extremely difficult, due to vague and non-specific symptoms. Serum lactate (SL) is commonly presented as a useful biomarker for the diagnosis or prognosis of AMI. The aim of our study was test SL (1) as a diagnostic marker and (2) as a prognostic marker for AMI. STUDY DESIGN: This was an ancillary multicentre case-control study. Patients with AMI at intensive care unit (ICU) admission were included (AMI group) and matched to ICU patients without AMI (control group)...
December 2022: Anaesthesia, Critical Care & Pain Medicine